Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% |
|
-.--% | -.--% |
20/06 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
18/06 | Cara Therapeutics to Idle 70% Workforce, Explore Alternatives After Scrapping Notalgia Paresthetica Program | MT |
Chart calendar Cara Therapeutics, Inc.
Upcoming events on Cara Therapeutics, Inc.
Past events on Cara Therapeutics, Inc.
04/06/2024 09:30 pm | Annual General Meeting |
14/05/2024 01:31 am | Q1 2024 Earnings Release |
09/04/2024 06:15 pm | Needham Healthcare Conference |
27/03/2024 07:30 pm | Investor Meeting - Key Opinion Leader |
05/03/2024 03:00 am | Q4 2023 Earnings Call |
05/03/2024 02:31 am | Q4 2023 Earnings Release |
22/01/2024 07:00 pm | Business Update Call |
30/11/2023 03:00 am | Piper Sandler Healthcare Conference |
16/11/2023 01:30 pm | Jefferies London Healthcare Conference |
15/11/2023 09:25 pm | Stifel Healthcare Conference |
14/11/2023 03:00 am | Q3 2023 Earnings Call |
14/11/2023 02:31 am | Q3 2023 Earnings Release |
11/09/2023 06:30 pm | H.C. Wainwright Global Investment Conference |
14/08/2023 | Stifel Biotech Summer Summit |
09/08/2023 05:30 pm | Canaccord Genuity Growth Conference |
08/08/2023 02:00 am | Q2 2023 Earnings Call |
08/08/2023 01:31 am | Q2 2023 Earnings Release |
21/06/2023 | Stifel Boston Conference |
09/06/2023 12:30 am | Jefferies Global Healthcare Conference |
01/06/2023 09:30 pm | Annual General Meeting |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 19,9 20,1 -1.27% | 135 65,7 105.51% | 23,0 28,8 -20.04% | 41,9 53,5 -21.76% | 21,0 27,5 -23.72% | 6,41 |
EBITDA Million USD | Released Forecast Spread | -111 -109 -1.86% | 5,59 -98,2 105.7% | -88,8 -74,9 -18.6% | -87,3 -75,1 -16.3% | -121 -77,9 -55.63% | -67,5 |
EBIT Million USD | Released Forecast Spread | -112 -113 1.23% | 5,39 -61,2 108.8% | -89,1 -80,2 -11.07% | -87,5 -75,4 -16.17% | -121 -113 -7.3% | -70,9 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -107 -110 2.86% | 7,72 -46,9 116.44% | -88,4 -87,3 -1.28% | -85,5 -74,5 -14.7% | -119 -106 -11.7% | -72,3 |
Net income Million USD | Released Forecast Spread | -106 -108 1.72% | 8,41 -53,3 115.78% | -88,4 -76,6 -15.4% | -85,5 -74,5 -14.7% | -119 -106 -11.7% | -72,3 |
EPS USD | Released Forecast Spread | -2,49 -2,54 1.97% | 0,18 -1,31 113.71% | -1,74 -1,54 -12.99% | -1,59 -1,36 -16.63% | -2,19 -1,96 -11.73% | -1,26 |
Announcement Date | 27/02/20 | 25/02/21 | 01/03/22 | 06/03/23 | 04/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4,79 2,26 111.93% | 23,0 21,0 9.36% | 10,8 8,86 22.11% | 3,26 14,5 -77.51% | 6,17 4,98 23.75% | 6,93 6,70 3.55% | 4,87 11,1 -56.17% | 3,00 9,13 -67.11% | 2,14 1,69 26.33% | 1,17 | 1,75 | 1,38 | 1,20 | 1,00 |
EBITDA Million USD | Released Forecast Spread | -27,8 -25,1 -10.89% | -4,41 -13,0 66.07% | -23,8 -23,4 -1.64% | -31,2 -19,1 -64.02% | -27,6 -30,2 8.51% | -32,3 -29,7 -8.87% | -28,8 -28,5 -1.19% | -32,5 10,8 -401.16% | -29,6 -22,2 -33.58% | -13,7 | -12,0 | -12,0 | ||
EBIT Million USD | Released Forecast Spread | -27,9 -30,8 9.27% | -4,47 -14,5 69.09% | -23,8 -23,6 -0.99% | -31,3 -19,3 -62.63% | -27,7 -29,4 5.8% | -32,3 -30,7 -5.51% | -28,9 -28,4 -1.63% | -32,6 -24,2 -34.96% | -29,7 -21,6 -37.46% | -14,8 | -14,0 | -12,4 | -16,5 | -17,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -27,7 -33,3 16.65% | -4,21 -14,0 69.99% | -23,2 -24,0 3.6% | -30,3 -19,2 -58.22% | -26,7 -28,6 6.76% | -31,5 -29,8 -5.81% | -28,0 -29,3 4.37% | -32,3 -19,9 -62.28% | -30,7 -21,6 -42.15% | -14,9 | -14,2 | -12,5 | -16,2 | -17,3 |
Net income Million USD | Released Forecast Spread | -27,7 -33,3 16.65% | -4,21 -14,0 69.99% | -23,2 -24,0 3.6% | -30,3 -19,2 -58.22% | -26,7 -28,6 6.76% | -31,5 -29,8 -5.81% | -28,0 -28,1 0.22% | -32,3 -19,9 -62.28% | -30,7 -21,6 -42.15% | -14,9 | -14,2 | -12,5 | -16,2 | -17,3 |
EPS USD | Released Forecast Spread | -0,52 -0,62 15.67% | -0,08 -0,26 68.98% | -0,43 -0,44 1.39% | -0,56 -0,36 -57.41% | -0,49 -0,52 5.57% | -0,58 -0,54 -7.65% | -0,52 -0,51 -2.61% | -0,59 -0,37 -61.64% | -0,56 -0,39 -42.68% | -0,27 | -0,23 | -0,20 | -0,20 | -0,21 |
Announcement Date | 09/05/22 | 08/08/22 | 07/11/22 | 06/03/23 | 15/05/23 | 07/08/23 | 13/11/23 | 04/03/24 | 13/05/24 | - | - | - | - | - |
11/07/2024 11:30 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
16/07/2024 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
23/07/2024 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 11:30 am | BIOGAIA AB: Q2 2024 Earnings Release |
24/07/2024 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
25/07/2024 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
25/07/2024 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
25/07/2024 10:30 am | UCB: Q2 2024 Earnings Release |
26/07/2024 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
30/07/2024 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Cara Therapeutics, Inc.
23/05/2024 03:13 pm | CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release |
14/05/2024 09:05 pm | GRIFOLS, S.A.: Q1 2024 Earnings Release |
14/05/2024 | NATURECELL CO.,LTD.: Q1 2024 Earnings Release |
10/05/2024 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
10/05/2024 | MEDY-TOX INC.: Q1 2024 Earnings Release |
10/05/2024 01:35 am | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
10/05/2024 01:35 am | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
09/05/2024 12:00 pm | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
09/05/2024 | HUGEL, INC.: Q1 2024 Earnings Release |
09/05/2024 01:46 am | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CARA Stock
- 69C Stock
- Calendar Cara Therapeutics, Inc.